TRAW
Traws Pharma Inc
NASDAQ: TRAW · HEALTHCARE · BIOTECHNOLOGY
$1.43
+10.00% today
Updated 2026-04-30
Market cap
$11.58M
P/E ratio
1.39
P/S ratio
4.15x
EPS (TTM)
$0.82
Dividend yield
—
52W range
$1 – $3
Volume
0.2M
Traws Pharma Inc (TRAW) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-14.17M | $1.63M | $-61.38M | $-57.65M | $-31.31M | $-15.81M | $-23.82M | $-22.70M | $-20.83M | $-23.07M | $-19.49M | $-16.29M | $-17.93M | $-29.79M | $-18.18M |
| Capital expenditures | $256000.00 | $279000.00 | $609000.00 | $228000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $55000.00 | $15000.00 | $0.00 | $0.00 | $14000.00 | $0.00 | $2.58M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $6000.00 | $13.84M | $8.02M | $5.07M | $3.79M | — | — | — | — | $369000.00 | $576000.00 | $1.17M | $1.30M | $1.39M | $728000.00 |
| Free cash flow | $-14.43M | $1.35M | $-61.99M | $-57.88M | $-31.31M | $-15.81M | $-23.82M | $-22.70M | $-20.89M | $-23.09M | $-19.49M | $-16.29M | $-17.95M | $-29.79M | $-20.77M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |